Subfoveal Choroidal Neovascularization in a Patient with Pre-Existing Pseudomacular Hole

Abstract

Purpose

To report concomitant use of fluorescein angiography (FA) and optical coherence tomography (OCT) in a case of pre-existing pseudomacular hole (PMH) and macular choroidal neovascularization (CNV) treated with photodynamic therapy (PDT).

Methods

Case report.

Results

A 63-year-old man who received laser treatment for branch retinal vein occlusion in 1993 developed an asymptomatic macular epiretinal membrane 2 years later. In 2001, the patient complained of metamorphopsia. Biomicroscopy showed a PMH, confirmed by OCT. One year later, metamorphopsia suddenly increased and visual acuity dropped from 20/20 to 20/70. FA and OCT revealed subfoveal occult CNV. PDT was successfully performed. FA and OCT were essential diagnostic tools during the follow-up.

Conclusions

The case presented stresses the importance of different tools for accurate diagnosis and proper follow-up of macular diseases.

Keywords

Pseudomacular hole Choroidal neovascularization Fluorescein angiography Optical coherence tomography Photodynamic therapy

Get full access to this article

View all access options for this article.

References

Gass

J.D.M.

. Macular dysfunction caused by vitreous and vit-reoretinal interface abnormalities. In: Gass

JDM

, ed. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol 2. Chap 12. St. Louis: CV Mosby; 1997: 947–8.

Smith

Assink

Kein

Risk factors for age-related macular degeneration. Pooled findings from three continents.

Ophthalmology 2001; 108: 697–704.

VIP Study Group.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomised clinical trial including lesions with occult no classic choroidal neovascularization: Verteporfin in photodynamic therapy report 2.

Am J Ophthalmol 2001; 131: 541–60.

Macular Photocoagulation Study Group.

Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study.

Arch Ophthalmol 1991; 109: 1242–57.

Guyer

D.R.

Yannuzzi

L.A.

Slakter

J.S.

Classification of choroidal neovascularization by digital indocyanine green videoangiography.

Ophthalmology 1996; 103: 2054–60.

Puliafito

C.A.

Hee

M.R.

Lin

C.P.

Imaging of macular diseases with optical coherence tomography.

Ophthalmology 1995; 102: 217–29.

Hee

M.R.

Baumal

C.R.

Puliafito

C.A.

Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.

Ophthalmology 1996; 103: 1260–70.

Wilkins

J.R.

Puliafito

C.A.

Hee

M.R.

Characterization of epiretinal membranes using optical coherence tomography.

Ophthalmology 1996; 103: 2142–51.

Verteporfin Roundtable 2000 and 2001 Participants, TAP Study Group Principal Investigators, and VIP Study Group Principal Investigators.

Guidelines for using verteporfin (Visudyne®) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Retina 2002; 22: 6–18.